Twist Bioscience Corporation

Industry

  • Digital Health
    • Artificial Intelligence
    • Disease Management
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
      • Bioinformatics
      • Genomics-Proteomics
    • Antisense, Oligonucleotides
    • Synthesis Technologies, Production Processes
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals

Other Names/Subsidiaries

  • Abveris
  • Genome Compiler, Twist Biopharma
  • Twist Bio Computing
  • Twist Pharmaceutical Solutions
See more in Biomedtracker

Latest on Twist Bioscience Corporation

Scrip

Deal Watch: QurAlis Targets Fragile-X Syndrome In Deals With Quiver, UMass

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Quiver, QurAlis To Combine Tech Platfor

In Vivo

The Impossible Task Of Regulating AI In Life Sciences

 
• By David Wild

Digital health decision makers recently gathered in Los Angeles, CA, at ViVE 2024 to share ideas for governance and regulation of artificial intelligence tools, like large language models. While their

Scrip

Deal Watch: Bayer Ties Up With Twist On Optimization Of Antibody Discovery

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bayer, Twist Collaboration Gives German

Scrip

Asia Deal Watch: US Biotech LIB Partners In Greater China With Hasten On PCSK9 Therapy

 
• By Joseph Haas, Jung Won Shin, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Hasten Gets Greater China Rights T